September 30, 2026 05:26 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
SIR row: Supreme Court to hear plea against CEC Gyanesh Kumar next week | Sambhal violence case: SC quashes key accused Mulla Afroz's NSA detention, slaps Rs 10 lakh cost on UP govt | Nandigram bypoll twist: Calcutta HC grants interim bail to Congress candidate Milan Pradhan till Oct 21 | Myanmar military airstrike horror: 49 killed, 58 injured as bombs hit crowded Rakhine market | Britain reopens refugee routes for Afghans, Palestinians as immigration and integration battle intensifies | New York Times executive shot dead: Elderly in-laws arrested amid bitter family feud over his 'trans' identity | Vijay's TVK makes Bengal entry: First party office opens in Purba Bardhaman amid state's political shake-up | SRFTI clash erupts over ABGP event: Students allege assault; BJP calls it ‘ugly face of Leftists’ | 'Asif bhai gun nikal': 17-year-old's chilling account of men posing as cops raping her in South Delhi park | Indian passport rules changed: New validity, fees for children and adults explained
Stock Market
Representational Photo: ChatGPT

Market update: Sensex tumbles 120 points, Nifty below 25,850 at closing bell

| @indiablooms | Dec 17, 2025, at 04:00 pm

Mumbai/IBNS: The Indian stock market ended Wednesday on a negative note, with BSE Sensex falling 120 points and NSE Nifty 50 closing below 25,850. Sensex settled at 84,559.65, while Nifty finished at 25,818.55.

Among sector movers, HDFC Bank, ICICI Bank, Asian Paints, and Titan were top losers, while shares of Maruti, TCS, Tata Steel, Reliance, and Bharti Airtel witnessed gains.

The Indian rupee, which opened at a fresh low, rebounded to settle at ₹90.38 against the US dollar, marking a 0.7% gain—the biggest single-day rise since October 15.

Meanwhile, dialysis service provider Nephrocare Health Services made a strong stock market debut, listing at a premium of about 7%. The shares debuted at ₹491.70 on the BSE (6.8% premium) and ₹490 on the NSE (6.52% premium), according to CNBC-TV18.

Nephrocare’s ₹871.05-crore initial public offering (IPO), open for subscription from December 10–12, was oversubscribed 13.96 times, highlighting strong investor demand.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.